| NLRP3 |
Q96P20
|
NLR family pyrin domain containing 3
|
|
8.1E-04 |
0.361 |
0.962 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| IL1RN |
P18510
|
interleukin 1 receptor antagonist
|
|
3.1E-02 |
0.373 |
0.923 |
| CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| COL1A1 |
P02452
|
collagen type I alpha 1 chain
|
|
1.00 |
0.430 |
0.808 |
| CHD7 |
Q9P2D1
|
chromodomain helicase DNA binding protein 7
|
|
1.00 |
0.441 |
0.846 |
| PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
| HBB |
P68871
|
hemoglobin subunit beta
|
|
1.2E-09 |
0.494 |
0.808 |
| RREB1 |
Q92766
|
ras responsive element binding protein 1
|
|
1.00 |
0.500 |
0.808 |
| AHI1 |
Q8N157
|
Abelson helper integration site 1
|
|
1.1E-25 |
0.513 |
0.846 |
| ATXN1 |
P54253
|
ataxin 1
|
|
0.97 |
0.534 |
0.769 |
| JMJD1C |
Q15652
|
jumonji domain containing 1C
|
|
1.00 |
0.517 |
0.769 |
| SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
| PIGL |
Q9Y2B2
|
phosphatidylinositol glycan anchor biosynthesis class L
|
|
6.2E-09 |
0.581 |
0.731 |
| PLAUR |
Q03405
|
plasminogen activator, urokinase receptor
|
|
5.3E-03 |
0.536 |
0.731 |
| KIDINS220 |
Q9ULH0
|
kinase D interacting substrate 220
|
|
7.4E-02 |
0.534 |
0.769 |
| FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
| GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
| RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
| FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
| PIGV |
Q9NUD9
|
phosphatidylinositol glycan anchor biosynthesis class V
|
|
1.5E-08 |
0.636 |
0.615 |
| PNKD |
Q8N490
|
PNKD metallo-beta-lactamase domain containing
|
|
4.1E-08 |
0.615 |
0.615 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| TNFRSF10C |
O14798
|
TNF receptor superfamily member 10c
|
|
3.2E-06 |
0.578 |
0.731 |